Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1
- PMID: 26621817
- PMCID: PMC4664893
- DOI: 10.1038/srep17369
Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1
Abstract
High-risk mutations in several genes predispose to both colorectal cancer (CRC) and endometrial cancer (EC). We therefore hypothesised that some lower-risk genetic variants might also predispose to both CRC and EC. Using CRC and EC genome-wide association series, totalling 13,265 cancer cases and 40,245 controls, we found that the protective allele [G] at one previously-identified CRC polymorphism, rs2736100 near TERT, was associated with EC risk (odds ratio (OR) = 1.08, P = 0.000167); this polymorphism influences the risk of several other cancers. A further CRC polymorphism near TERC also showed evidence of association with EC (OR = 0.92; P = 0.03). Overall, however, there was no good evidence that the set of CRC polymorphisms was associated with EC risk, and neither of two previously-reported EC polymorphisms was associated with CRC risk. A combined analysis revealed one genome-wide significant polymorphism, rs3184504, on chromosome 12q24 (OR = 1.10, P = 7.23 × 10(-9)) with shared effects on CRC and EC risk. This polymorphism, a missense variant in the gene SH2B3, is also associated with haematological and autoimmune disorders, suggesting that it influences cancer risk through the immune response. Another polymorphism, rs12970291 near gene TSHZ1, was associated with both CRC and EC (OR = 1.26, P = 4.82 × 10(-8)), with the alleles showing opposite effects on the risks of the two cancers.
Figures
References
-
- Dunlop M. G. et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 6, 105–110 (1997). - PubMed
-
- Hendriks Y. M. et al. Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Gastroenterology 127, 17–25 (2004). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- G1001799/MRC_/Medical Research Council/United Kingdom
- P30 CA015704/CA/NCI NIH HHS/United States
- MR/K014781/1/MRC_/Medical Research Council/United Kingdom
- U24 CA074806/CA/NCI NIH HHS/United States
- 13154/CRUK_/Cancer Research UK/United Kingdom
- 16563/CRUK_/Cancer Research UK/United Kingdom
- U01 CA097735/CA/NCI NIH HHS/United States
- 090532/Z/09/Z/WT_/Wellcome Trust/United Kingdom
- WT_/Wellcome Trust/United Kingdom
- U01 CA074783/CA/NCI NIH HHS/United States
- U24 CA074799/CA/NCI NIH HHS/United States
- U01 CA074800/CA/NCI NIH HHS/United States
- U01 CA074799/CA/NCI NIH HHS/United States
- MC_PC_U127527198/MRC_/Medical Research Council/United Kingdom
- U24 CA074783/CA/NCI NIH HHS/United States
- 12076/CRUK_/Cancer Research UK/United Kingdom
- 16565/CRUK_/Cancer Research UK/United Kingdom
- 16459/CRUK_/Cancer Research UK/United Kingdom
- U24 CA074794/CA/NCI NIH HHS/United States
- MC_U127527198/MRC_/Medical Research Council/United Kingdom
- U24 CA097735/CA/NCI NIH HHS/United States
- U01 CA074794/CA/NCI NIH HHS/United States
- MR/N01104X/1/MRC_/Medical Research Council/United Kingdom
- U01 CA167551/CA/NCI NIH HHS/United States
- R01 CA143237/CA/NCI NIH HHS/United States
- MR/K018647/1/MRC_/Medical Research Council/United Kingdom
- UM1 CA167551/CA/NCI NIH HHS/United States
- U01 CA122839/CA/NCI NIH HHS/United States
- U01 CA074806/CA/NCI NIH HHS/United States
- U24 CA074800/CA/NCI NIH HHS/United States
- 16561/CRUK_/Cancer Research UK/United Kingdom
- 10124/CRUK_/Cancer Research UK/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
